Le Lézard
Classified in: Science and technology, Business
Subject: CXP

SKYDEX Builds Momentum: A Testament to Vision, Focus and Effective Execution


SKYDEX Attains Remarkable 70% Top-Line Growth Over the Last Two Years Showcasing Industry Leadership via Disciplined Execution and Best-in-Class Solutions

CENTENNIAL, Colo., March 12, 2024 /PRNewswire/ -- SKYDEX, a global leader in advanced impact mitigation and energy absorption solutions, proudly announces its differential corporate growth, marking a significant milestone in its journey of innovation and success. With a strategic focus on top-line growth, expanded manufacturing capabilities, cost optimization, international expansion, and forging impactful partnerships, SKYDEX has achieved remarkable progress, positioning itself for an even brighter future.

"SKYDEX is on a trajectory of sustainable growth and success that is fueled by a committed team and revolutionary technology," said Alvaro Vaselli, SKYDEX President and CEO. "We are laser focused on our mission of protecting people and things that matter as we continue to accelerate growth, innovation, and value creation for all stakeholders."

Key Highlights of SKYDEX's Corporate Growth:

  1. Top-Line Growth: SKYDEX has witnessed over 70% top-line growth over the last two years, reflecting the efficacy of its business strategies, market agility, and unwavering commitment to innovation and producing the best products to protect human life.

  2. Increased Manufacturing Output: Leveraging cutting-edge manufacturing capabilities and process optimization, SKYDEX has increased in-house manufacturing from 20% to over 65% over the last 5 years, ensuring enhanced efficiency and scalability to meet growing market demands.

  3. Cost Reduction for Improved Pricing: Through rigorous cost management initiatives and operational efficiencies, SKYDEX has successfully reduced costs, enabling it to offer better pricing to customers without compromising on quality or service.

  4. International Growth and Diversification: With a strategic vision to expand globally, SKYDEX has diversified its customer base, transitioning from a predominantly domestic focus to a more balanced international presence. From serving a base of 90% domestic customers, SKYDEX has successfully shifted to 70-30, with a clear trajectory towards achieving a 50-50 domestic-international split in the near future.

  5. Expanding Partnerships: In addition to a reliable base of loyal customers, SKYDEX has recently established new strategic partnerships with industry leaders and innovators, fostering synergies and driving mutual growth. These partnerships have not only expanded SKYDEX's market reach but also enriched its product offerings.

Looking Ahead:

With a robust pipeline of multi-year revenue generating opportunities, SKYDEX is poised for continued success and expansion. With a proven track record of innovation, SKYDEX is primed to capitalize on large emerging opportunities, innovate for expanding market requirements, and continue trailblazing in protective technologies.

SOURCE SKYDEX Technologies, Inc.


These press releases may also interest you

at 02:34
Elbit Systems Ltd.  ("Elbit Systems" or the "Company") announced today that it was awarded an initial contract of approximately $37 million to supply Iron Fist Active Protection Systems (APS) to General Dynamics Ordnance and Tactical Systems...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
U.S.-based tech startup Iozera, in collaboration with the Government of Morocco, announces an initiative set to transform the AI industry. Iozera has announced the signing of a Memorandum of Understanding (MOU) for the establishment of a pioneering...

4 mai 2024
OKX, a leading Web3 technology company, has issued updates for May 3, 2024. OKX today announced that its Web3 Wallet is now...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
With a remarkable achievement of 81.556 billion yuan in operating revenue, marking an 11.74% increase from the previous year, and a net profit attributable to shareholders of 7.039 billion yuan, soaring by 27.21%, JA Solar hit historic highs in both...



News published on and distributed by: